General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Phillips(MODEST), Anteris(SIGNIFICANT), Tricares(NONE), Moray Medical(MODEST), Helix Valve Repair(SIGNIFICANT), Nyra(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: X-Dot(SIGNIFICANT), Cardiomech(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Edwards Lifesciences(NONE), Medtronic(NONE), Boston Scientific(NONE), Abbott Vascular(NONE), JenaValve(NONE) OTHER FINANCIAL BENEFIT: Dura Biotech(MODEST), MicroInterventional Devices(NONE), TriFlo(NONE), Adona(NONE), Tioga(SIGNIFICANT), Supira(MODEST), Thubrikar Aortic Valve, Inc(NONE)

View Full Disclosure